[{"address1": "IDA Business Park", "city": "Bray", "zip": "A98 H5C8", "country": "Ireland", "phone": "353 1 276 9800", "fax": "353 1 276 9888", "website": "https://www.trinitybiotech.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.", "fullTimeEmployees": 380, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Gillard", "age": 42, "title": "President, CEO, Company Secretary & Director", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 710000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronan  O'Caoimh", "age": 67, "title": "Founder, Director & Executive Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Walsh Ph.D.", "age": 65, "title": "Executive Director of Business Development & Executive Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Des  Fitzgerald", "age": 33, "title": "Interim Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacqueline  O'Neill", "age": 50, "title": "Director of Operations", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Simon  Dunne", "age": 49, "title": "Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Keating Ph.D.", "age": 50, "title": "Chief Technology Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eibhlin  Kelly", "age": 39, "title": "Chief Information Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Colm  Molloy", "age": 52, "title": "Group Director of Human Resources & Culture", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.trinitybiotech.com/InvestorRelations/Pages/Company%20Overview.aspx", "maxAge": 86400, "priceHint": 4, "previousClose": 3.47, "open": 3.5, "dayLow": 2.57, "dayHigh": 3.5, "regularMarketPreviousClose": 3.47, "regularMarketOpen": 3.5, "regularMarketDayLow": 2.57, "regularMarketDayHigh": 3.5, "exDividendDate": 1433462400, "fiveYearAvgDividendYield": 1.19, "beta": 1.167, "trailingPE": 0.65411764, "forwardPE": -9.266666, "volume": 157979, "regularMarketVolume": 157979, "averageVolume": 36257, "averageVolume10days": 123660, "averageDailyVolume10Day": 123660, "bid": 2.7, "ask": 2.86, "bidSize": 100, "askSize": 100, "marketCap": 26314118, "fiftyTwoWeekLow": 1.49, "fiftyTwoWeekHigh": 5.5, "priceToSalesTrailing12Months": 0.4640365, "fiftyDayAverage": 1.8536, "twoHundredDayAverage": 2.38365, "currency": "USD", "enterpriseValue": 693809856, "profitMargins": -0.3796, "floatShares": 89886875, "sharesOutstanding": 9465510, "sharesShort": 7397, "sharesShortPriorMonth": 1860, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.23665, "heldPercentInstitutions": 0.31295002, "shortRatio": 0.34, "shortPercentOfFloat": 0.0019, "impliedSharesOutstanding": 7641510, "bookValue": -2.576, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -33880000, "trailingEps": 4.25, "forwardEps": -0.3, "lastSplitFactor": "1:5", "lastSplitDate": 1708646400, "enterpriseToRevenue": 12.235, "enterpriseToEbitda": -52.025, "52WeekChange": -0.3346154, "SandP52WeekChange": 0.2322551, "lastDividendValue": 1.1, "lastDividendDate": 1433462400, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TRIB", "underlyingSymbol": "TRIB", "shortName": "Trinity Biotech plc", "longName": "Trinity Biotech plc", "firstTradeDateEpochUtc": 719674200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f11095f5-a45d-3fd0-867a-c30f29ce8486", "messageBoardId": "finmb_397947", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.78, "recommendationKey": "none", "totalCash": 5776000, "totalCashPerShare": 0.033, "ebitda": -13336000, "totalDebt": 85636000, "quickRatio": 1.025, "currentRatio": 2.018, "totalRevenue": 56707000, "revenuePerShare": 7.119, "returnOnAssets": -0.10471, "freeCashflow": 4728750, "operatingCashflow": -11658000, "revenueGrowth": -0.008, "grossMargins": 0.34209, "ebitdaMargins": -0.23517, "operatingMargins": -0.20681, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-14"}]